These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 36247234)

  • 21. Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential.
    Xiang H; Liu QP
    World J Gastroenterol; 2022 Dec; 28(47):6689-6701. PubMed ID: 36620345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronavirus disease-2019 and the intestinal tract: An overview.
    Alberca GGF; Solis-Castro RL; Solis-Castro ME; Alberca RW
    World J Gastroenterol; 2021 Apr; 27(13):1255-1266. PubMed ID: 33833480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of gut microbiota with the pathogenesis of SARS-CoV-2 Infection in people living with HIV.
    Ishizaka A; Koga M; Mizutani T; Yamayoshi S; Iwatsuki-Horimoto K; Adachi E; Suzuki Y; Kawaoka Y; Yotsuyanagi H
    BMC Microbiol; 2024 Jan; 24(1):6. PubMed ID: 38172680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities - Role of gut microbiota dysbiosis.
    Viana SD; Nunes S; Reis F
    Ageing Res Rev; 2020 Sep; 62():101123. PubMed ID: 32683039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19 and diarrhea: putative mechanisms and management.
    Juthi RT; Sazed SA; Sarmin M; Haque R; Alam MS
    Int J Infect Dis; 2023 Jan; 126():125-131. PubMed ID: 36403817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The gut microbiome: a missing link in understanding the gastrointestinal manifestations of COVID-19?
    Brooks EF; Bhatt AS
    Cold Spring Harb Mol Case Stud; 2021 Apr; 7(2):. PubMed ID: 33593727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Profiles of gut microbiota associated with clinical outcomes in patients with different stages of SARS-CoV-2 infection.
    Krasaewes K; Chaiwarith R; Chattipakorn N; Chattipakorn SC
    Life Sci; 2023 Nov; 332():122136. PubMed ID: 37783267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Features and Pathophysiological Mechanisms of COVID-19-associated Gastrointestinal Manifestations.
    Aslan AT; Şimşek H
    Euroasian J Hepatogastroenterol; 2021; 11(2):81-86. PubMed ID: 34786361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut distress and intervention
    Moon Y
    Front Public Health; 2023; 11():1098774. PubMed ID: 37139365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmunity and COVID-19 - The microbiotal connection.
    Katz-Agranov N; Zandman-Goddard G
    Autoimmun Rev; 2021 Aug; 20(8):102865. PubMed ID: 34118455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. It Ain't Over 'Til It's Over: SARS CoV-2 and Post-infectious Gastrointestinal Dysmotility.
    Coles MJ; Masood M; Crowley MM; Hudgi A; Okereke C; Klein J
    Dig Dis Sci; 2022 Dec; 67(12):5407-5415. PubMed ID: 35357608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastrointestinal and hepatic diseases during the COVID-19 pandemic: Manifestations, mechanism and management.
    Mohamed DZ; Ghoneim ME; Abu-Risha SE; Abdelsalam RA; Farag MA
    World J Gastroenterol; 2021 Jul; 27(28):4504-4535. PubMed ID: 34366621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurological post-acute sequelae of SARS-CoV-2 infection.
    Takao M; Ohira M
    Psychiatry Clin Neurosci; 2023 Feb; 77(2):72-83. PubMed ID: 36148558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut microbiota and Covid-19- possible link and implications.
    Dhar D; Mohanty A
    Virus Res; 2020 Aug; 285():198018. PubMed ID: 32430279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID.
    Ancona G; Alagna L; Alteri C; Palomba E; Tonizzo A; Pastena A; Muscatello A; Gori A; Bandera A
    Front Immunol; 2023; 14():1080043. PubMed ID: 36969243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential implications of SARS-CoV-2 oral infection in the host microbiota.
    Xiang Z; Koo H; Chen Q; Zhou X; Liu Y; Simon-Soro A
    J Oral Microbiol; 2020 Nov; 13(1):1853451. PubMed ID: 33312449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An overview of the gut side of the SARS-CoV-2 infection.
    Barbosa da Luz B; de Oliveira NMT; França Dos Santos IW; Paza LZ; Braga LLVM; Platner FDS; Werner MFP; Fernandes ES; Maria-Ferreira D
    Intest Res; 2021 Oct; 19(4):379-385. PubMed ID: 33142370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.
    Moghimi N; Di Napoli M; Biller J; Siegler JE; Shekhar R; McCullough LD; Harkins MS; Hong E; Alaouieh DA; Mansueto G; Divani AA
    Curr Neurol Neurosci Rep; 2021 Jun; 21(9):44. PubMed ID: 34181102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advance of ACE2 and microbiota dysfunction in COVID-19 pathogenesis.
    Yu Z; Yang Z; Wang Y; Zhou F; Li S; Li C; Li L; Zhang W; Li X
    Heliyon; 2021 Jul; 7(7):e07548. PubMed ID: 34296023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut-lung axis and dysbiosis in COVID-19.
    Aktas B; Aslim B
    Turk J Biol; 2020; 44(3):265-272. PubMed ID: 32595361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.